Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide begins acting on appetite-regulating pathways within the first week of treatment, but meaningful, visible weight loss typically takes four to eight weeks to become apparent. Most people notice their hunger quietening before the scale moves much. These are prescription-only medicines assessed and prescribed by a clinician — the pace of progress is shaped by dose, lifestyle, and individual biology, not by the medicine alone. Here is what the clinical evidence shows about timing, so you know what to look for and when.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
People sometimes stop semaglutide in the first month because the number on the scales has barely shifted. It is an understandable reaction, and it is worth gently setting the record straight. The medicine is not slow to start, the biology is just sequenced differently from what you might expect.
Semaglutide is a GLP-1 receptor agonist. It mimics a gut hormone that signals fullness to the brain, slows the rate at which the stomach empties, and reduces appetite. Those effects begin within days of the first injection. What changes first is how food feels, not how much you weigh. A smaller portion feels adequate. Meals feel less urgent. Cravings for high-calorie foods often soften. For many people this shift in appetite is the clearest early sign that the medicine is working, even when the scale has not yet moved in a way that feels significant.
Weight loss itself follows. At the starter dose of 0.25 mg, the medicine is designed to settle your system rather than drive rapid loss. The prescriber titrates the dose upward roughly every four weeks, and meaningful weight reduction tends to build alongside those increases. Expecting dramatic results in week two, at the lowest dose, is the misunderstanding that causes premature disappointment. You can read more about how the broader timing picture unfolds on our guide to how long semaglutide takes to work.
In the landmark STEP 1 trial) 68 weeks, nearly 2,000 adults with obesity or overweight plus a weight-related condition, semaglutide 2.4 mg versus placebo, the average weight loss at the end of the study was around 15% of body weight, reported in the New England Journal of Medicine. What the published data also shows is that loss accelerated progressively. Early weeks produced modest numbers; later weeks, as the dose reached maintenance, produced the steeper curves.
For most participants, noticeable weight loss was detectable by weeks four to eight. By week 16, results were clearer. By weeks 36 to 52, the full effect of the maintenance dose was visible. This gradual accumulation is a feature, not a flaw. Slower titration means better tolerability, nausea and digestive discomfort are the most commonly reported side effects, and they are generally milder when the dose increases are spaced out. The NHS medicines page for semaglutide explains the dosing steps and what to expect at each stage.
Individual variation is real. Genetics, starting weight, how closely someone follows dietary guidance, and activity levels all influence pace. The average weight loss percentages from trials give a useful benchmark, but they are averages across thousands of people, not predictions for any single person.
Week one to four: appetite changes are the headline. Portions that felt normal may start to feel generous. Some people report that the pull toward snacking simply fades. Weight loss at this stage is often one to three pounds, sometimes more, and if you are wondering how fast semaglutide works in these opening weeks, the honest answer is that the appetite shift is usually the first thing you notice rather than a dramatic drop on the scales. The medicine is doing its job; the dose is still building.
Month two to three: many people hit their first period of clearly visible progress. The dose will typically have increased at least once. Energy intake has dropped, and the body has started drawing on stored fat. This is where a lot of the motivation to continue comes from, and it is worth knowing in advance, so the first few weeks do not feel like a false start.
Month three onward: with the dose approaching or at maintenance, progress tends to be steadier and more predictable. Combining the medicine with consistent protein intake, adequate hydration, and some physical activity makes a measurable difference to both the rate and the sustainability of results. Those practical elements are worth discussing with your prescriber from the start. Our Wegovy overview covers more about how the treatment fits into a wider plan, including a closer look at how fast Wegovy works as the dose increases, and our weight loss treatments page sets out all the options we currently offer.
One thing that sometimes surprises people: the medicine can keep working after you feel you have plateaued. A plateau at month four does not necessarily mean the medicine has stopped. It may mean the dose is ready to increase, or that lifestyle factors have room to shift. A prescriber review at that point is more useful than stopping.
Knowing the honest timeline before you start is one of the most practical things you can do. It makes the first weeks less frustrating and the later months more rewarding, because you know what phase you are in. For context on how private semaglutide treatment works and what it costs, our Wegovy ordering guide walks through the process from consultation to delivery, including what is included in the price. Questions about how semaglutide compares to other GLP-1 options are answered by our prescribers as part of the free consultation, which you can start here. These are prescription-only medicines, a clinician reviews your full picture before anything is prescribed, and that review happens the same day you submit.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.